Caricamento...

Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis

MS (multiple sclerosis) is a chronic autoimmune and neurodegenerative pathology of the CNS (central nervous system) affecting approx. 2.5 million people worldwide. Current and emerging DMDs (disease-modifying drugs) predominantly target the immune system. These therapeutic agents slow progression an...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Tan, Yossan-Var, Waschek, James A
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Neurochemistry 2011
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3189630/
https://ncbi.nlm.nih.gov/pubmed/21895607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/AN20110024
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !